title: Crystal structure of human branched-chain alpha-ketoacid dehydrogenase and the molecular basis of multienzyme complex deficiency in maple syrup urine disease.
abstract: BACKGROUND
  Mutations in components of the extraordinarily large alpha-ketoacid dehydrogenase multienzyme complexes can lead to serious and often fatal disorders in humans, including maple syrup urine disease (MSUD). In order to obtain insight into the effect of mutations observed in MSUD patients, we determined the crystal structure of branched-chain alpha-ketoacid dehydrogenase (E1), the 170 kDa alpha(2)beta(2) heterotetrameric E1b component of the branched-chain alpha-ketoacid dehydrogenase multienzyme complex.
  
  
  RESULTS
  The 2.7 A resolution crystal structure of human E1b revealed essentially the full alpha and beta polypeptide chains of the tightly packed heterotetramer. The position of two important potassium (K(+)) ions was determined. One of these ions assists a loop that is close to the cofactor to adopt the proper conformation. The second is located in the beta subunit near the interface with the small C-terminal domain of the alpha subunit. The known MSUD mutations affect the functioning of E1b by interfering with the cofactor and K(+) sites, the packing of hydrophobic cores, and the precise arrangement of residues at or near several subunit interfaces. The Tyr-->Asn mutation at position 393-alpha occurs very frequently in the US population of Mennonites and is located in a unique extension of the human E1b alpha subunit, contacting the beta' subunit.
  
  
  CONCLUSIONS
  Essentially all MSUD mutations in human E1b can be explained on the basis of the structure, with the severity of the mutations for the stability and function of the protein correlating well with the severity of the disease for the patients. The suggestion is made that small molecules with high affinity for human E1b might alleviate effects of some of the milder forms of MSUD.
authors.affiliation: Department of Biological Structure, University of Washington School of Medicine, Seattle 98195, USA.
authors.forename: A
authors.initials: A
authors.lastname: AEvarsson
authors.forename: J L
authors.initials: JL
authors.lastname: Chuang
authors.forename: R M
authors.initials: RM
authors.lastname: Wynn
authors.forename: S
authors.initials: S
authors.lastname: Turley
authors.forename: D T
authors.initials: DT
authors.lastname: Chuang
authors.forename: W G
authors.initials: WG
authors.lastname: Hol
mesh_terms: D042942:3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide); D000595:Amino Acid Sequence; D003067:Coenzymes / Q000378:metabolism; D018360:Crystallography, X-Ray; D006801:Humans; D007658:Ketone Oxidoreductases / Q000737:chemistry* / Q000235:genetics; D008375:Maple Syrup Urine Disease / Q000201:enzymology* / Q000235:genetics; D008958:Models, Molecular; D008969:Molecular Sequence Data; D009097:Multienzyme Complexes / Q000737:chemistry* / Q000172:deficiency* / Q000235:genetics; D009154:Mutation; D011188:Potassium / Q000737:chemistry; D011485:Protein Binding; D011487:Protein Conformation; D016958:Pseudomonas putida / Q000201:enzymology; D017386:Sequence Homology, Amino Acid
chemical_list: D003067:Coenzymes; D009097:Multienzyme Complexes; D007658:Ketone Oxidoreductases; D042942:3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide); D011188:Potassium